Citadel Advisors - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 33 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$32,000
+18.5%
77,254
+174.9%
0.00%
Q3 2018$27,000
-79.4%
28,100
-48.0%
0.00%
Q2 2018$131,000
+244.7%
54,022
+244.1%
0.00%
Q1 2018$38,000
+35.7%
15,700
+36.5%
0.00%
Q4 2017$28,000
-36.4%
11,500
-18.4%
0.00%
Q3 2017$44,000
-42.9%
14,100
-26.6%
0.00%
Q2 2017$77,000
-2.5%
19,200
-53.0%
0.00%
Q4 2016$79,00040,8630.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$777,0000.14%
SEARLE & CO. 17,250$64,0000.04%
Jefferies Group LLC 259,200$959,0000.01%
Renaissance Technologies 740,650$2,740,0000.00%
Virtu KCG Holdings LLC 28,739$106,0000.00%
GROUP ONE TRADING, L.P. 19,945$74,0000.00%
SIMPLEX TRADING, LLC 4,950$18,0000.00%
IFP Advisors, Inc 427$2,0000.00%
Advisor Group, Inc. 177$1,0000.00%
BANK OF AMERICA CORP /DE/ 8,363$31,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders